DNA Diagnostic Solutions For Clinical Applications
Contact Us
MultiGEN Diagnostics

New licensing opportunities for MultiGEN based platform technologies

  • MultiGEN IC-Code is the only molecular diagnostics platform technology that has a true internal control. Hence, IC-Code based assays possess the highest level of sensitivity and specificity. These novel features have unique applications in two areas:
    • Blood donation screening
      More than 15.7 million blood donations are screened annually for important blood borne pathogens such as HIV, Hepatitis B, Hepatitis C and West Nile Virus. MultiGEN IC-code based blood assays can detect all three pathogens with an internal control for each pathogens ensuring no false negatives. Read more….
    • Bio processing
      Animal products (e.g. serum) used in the manufacturing of bio-pharmaceuticals could carry viral and bacterial pathogens. Further, there could be contamination during the manufacturing process itself. Therefore, it is of utmost importance that bio-pharmaceutical manufacturing processes need to be checked at various stages for potential pathogens. MultiGEN provides the ultimate test that can detect any pathogen at a set threshold level. Read more…
  • MultiGEN PerMed platform technology in Pharmacovigilance (Drug Safety)
    Antibody-based bio-pharmaceuticals have become the drug of choice in personalized therapy for a rapidly growing number of diseases, including cancer. These antibodies are directed to specific targets for the disease. For example, in rheumatoid arthritis, the drug Remicade binds to Tumor Necrosis Factor (TNF alpha), and the drug R-7050 blocks the TNF alpha receptor. However, the protein structure of ligand TNF alpha and its receptors varies in individual patients. MultiGEN tests are based on gene expression combined with computational modeling that will increase the rate of success in drug development, as well as predict potential efficacy of these agents on an individual basis leading, to better patent selection for these expensive therapies, optimal treatment outcomes, and the avoidance of adverse effects.